• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Magstim Acquires Electrical Geodesics, Inc. (EGI) Product Portfolio

Share:

July 7, 2020

E24EGN Study of brain

Magstim, the global leader in Transcranial Magnetic Stimulation (TMS), today announced an agreement to acquire the product portfolio of Electrical Geodesics, Inc. (EGI) from Royal Philips (NYSE:PHG; AEX: PHIA), a global leader in health technology. EGI designs non-invasive multimodal technologies to monitor brain activity and deliver transcranial electrical stimulation in brain research. Magstim will acquire EGI hardware, software and sensor nets assets and will immediately manage global sales, service and support. Philips will support the transition through the end of 2020.

“This adds high-density EEG to our product portfolio supporting more than 1,200 research labs and clinics that focus on mental health, brain disorders and cognitive neuroscience,” said Lothar Krinke, Group CEO for Magstim. “Magstim has been pioneering and advancing transcranial magnetic stimulation for 30 years. High-density EEG closes the loop for the development of a comprehensive system for non-invasive neuromodulation. Magstim and EGI share a legacy and passion for innovation in neuroscience.”

Electroencephalography (EEG) is used to evaluate the electrical activity in the brain. EGI’s proprietary dense array EEG technology gathers data from more electrodes than conventional EEG. EGI’s Geodesic Sensor Net (GSN) is used globally by neuroscience researchers because of its ease of use, comfort and ability to produce high-resolution data.

“Merging TMS and EEG facilitates future innovations leading to personalized treatments based on biological markers,” said Dr. Alvaro Pascual-Leone, MD, PhD, Professor of Neurology at Harvard Medical School. “I am confident this will lead to better patient outcomes.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Magstim will continue a presence in EGI’s Oregon office supported by Magstim’s global offices in the UK, Netherlands and Minneapolis. Magstim is backed by Telegraph Hill Partners, a San Francisco based private equity company. Magstim is also member of Medical Alley, the world’s leading health technology innovation cluster and home to the nation’s largest private health insurer and more than 1,000 healthcare companies, employing millions worldwide. Magstim’s sister brands include Neurosign and Technomed.

MAGSTIM is the pioneer of Transcranial Magnetic Stimulation. TMS is a research tool and an effective, non-invasive, outpatient therapy that is cleared by the FDA for major depressive disorder.

Source: Biospace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Backed by Redesign Health, MedArrive Launches with $4.5M in Funding for Care Management PlatformBacked by Redesign Health, MedArrive Launches with $4.5M in Funding for Care Management Platform
  • TrestleTree Acquires Opioid Risk Prediction ToolTrestleTree Acquires Opioid Risk Prediction Tool
  • COVID-19 Patient Registry Launches to Monitor Symptomatic and Asymptomatic COVID-19 PatientsCOVID-19 Patient Registry Launches to Monitor Symptomatic and Asymptomatic COVID-19 Patients
  • How Healthcare Blockchain Can Help Overcome IT BarriersHow Healthcare Blockchain Can Help Overcome IT Barriers
  • Digital MSK Company Kaia Health Partners to Offer In-Person Physical TherapyDigital MSK Company Kaia Health Partners to Offer In-Person Physical Therapy
  • Tech companies amplify healthcare investments, backed by acquisitions and IP’sTech companies amplify healthcare investments, backed by acquisitions and IP’s
  • Avanlee App Launches to Help Family Caregivers Coordinate Senior HealthcareAvanlee App Launches to Help Family Caregivers Coordinate Senior Healthcare
  • Stellar Biotechnologies in reverse merger with Edesa Biotech; shares shoot higherStellar Biotechnologies in reverse merger with Edesa Biotech; shares shoot higher

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications